title: B cell depletion therapy and eosinophilic granulomatosis with polyangiitis with hepatic involvement.
authors.affiliation: Lupus Research Unit, Rayne Institute, St Thomas' Hospital, London, UK.
authors.forename: Antigoni
authors.initials: A
authors.lastname: Grigoriou
authors.affiliation: Lupus Research Unit, Rayne Institute, St Thomas' Hospital, London, UK.
authors.forename: Alison
authors.initials: A
authors.lastname: Endean
authors.affiliation: Lupus Research Unit, Rayne Institute, St Thomas' Hospital, London, UK.
authors.forename: Shirish R
authors.initials: SR
authors.lastname: Sangle
authors.affiliation: Lupus Research Unit, Rayne Institute, St Thomas' Hospital, London, UK. david.d'cruz@kcl.ac.uk.
authors.forename: David P
authors.initials: DP
authors.lastname: D'Cruz
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D015267:Churg-Strauss Syndrome / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008099:Liver / Q000000981:diagnostic imaging / Q000473:pathology*; D008212:Lymphocyte Depletion; D008775:Methylprednisolone / Q000627:therapeutic use; D011859:Radiography; D019233:Retreatment; D000069283:Rituximab; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab; D016572:Cyclosporine; D008775:Methylprednisolone